• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于二硫代氨基甲酸金(III)配合物的选择性抗癌和抗菌金属药物

Selective Anticancer and Antimicrobial Metallodrugs Based on Gold(III) Dithiocarbamate Complexes.

作者信息

Abás Elisa, Aguirre-Ramírez Diego, Laguna Mariano, Grasa Laura

机构信息

Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea, Universidad de Zaragoza-CSIC, Plaza S. Francisco s/n, 50009 Zaragoza, Spain.

Departamento de Farmacología, Fisiología y Medicina Legal y Forense, Facultad de Veterinaria, Universidad de Zaragoza, Miguel Servet, 177, 50013 Zaragoza, Spain.

出版信息

Biomedicines. 2021 Nov 26;9(12):1775. doi: 10.3390/biomedicines9121775.

DOI:10.3390/biomedicines9121775
PMID:34944591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8698672/
Abstract

New dithiocarbamate cycloaurated complexes have been synthesized and their physicochemical and in vitro antitumor properties have been evaluated. All the performed studies highlighted good transport through the blood and biodistribution, according to the balance between the properties of hydrophilicity/lipophilicity and the binding of moderate strength to the BSA protein. Furthermore, none of the complexes exhibited reduction or decomposition reactions, presenting excellent physiological stability. The in vitro cytotoxic effect was evaluated on human colon cancer cell line Caco-2/TC7, and the complexes showed great antiproliferative activity and excellent selectivity, as much less effect was detected on normal Caco-2/TC7 cells. Most of the complexes exhibit antiproliferative activity that was better than or similar to auranofin, and at least nine times better than that of cisplatin. Its action mechanism is still under discussion since no evidence of cell cycle arrest was found, but an antioxidant role was shown for some of the selective complexes. All complexes were also tested as antimicrobial drugs, exhibiting good activity towards and . bacteria and and fungi.

摘要

新型二硫代氨基甲酸盐环金属化金配合物已被合成,并对其理化性质和体外抗肿瘤特性进行了评估。所有开展的研究都表明,根据亲水性/亲脂性特性之间的平衡以及与牛血清白蛋白(BSA)蛋白的中等强度结合,这些配合物在血液中的转运和生物分布良好。此外,没有一种配合物表现出还原或分解反应,具有出色的生理稳定性。在人结肠癌细胞系Caco-2/TC7上评估了体外细胞毒性作用,这些配合物表现出很强的抗增殖活性和出色的选择性,因为在正常Caco-2/TC7细胞上检测到的作用要小得多。大多数配合物表现出的抗增殖活性优于或类似于金诺芬,且至少比顺铂强九倍。由于未发现细胞周期停滞的证据,其作用机制仍在讨论中,但一些选择性配合物显示出抗氧化作用。所有配合物还作为抗菌药物进行了测试,对某些细菌和真菌表现出良好的活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/cc2fc8bb8171/biomedicines-09-01775-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/b0463a74a8c4/biomedicines-09-01775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/7f9e1bda4b54/biomedicines-09-01775-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/b7fca39420f1/biomedicines-09-01775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/d66e08880d6f/biomedicines-09-01775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/ededb2ad6732/biomedicines-09-01775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/beb3081ad0cd/biomedicines-09-01775-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/cc2fc8bb8171/biomedicines-09-01775-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/b0463a74a8c4/biomedicines-09-01775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/7f9e1bda4b54/biomedicines-09-01775-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/b7fca39420f1/biomedicines-09-01775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/d66e08880d6f/biomedicines-09-01775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/ededb2ad6732/biomedicines-09-01775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/beb3081ad0cd/biomedicines-09-01775-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/634f/8698672/cc2fc8bb8171/biomedicines-09-01775-g006.jpg

相似文献

1
Selective Anticancer and Antimicrobial Metallodrugs Based on Gold(III) Dithiocarbamate Complexes.基于二硫代氨基甲酸金(III)配合物的选择性抗癌和抗菌金属药物
Biomedicines. 2021 Nov 26;9(12):1775. doi: 10.3390/biomedicines9121775.
2
Anticancer Activity of Alkynylgold(I) with P(NMe) Phosphane in Mouse Colon Tumors and Human Colon Carcinoma Caco-2 Cell Line.炔基金(I)与 P(NMe)膦配合物的抗肿瘤活性在小鼠结肠肿瘤和人结肠癌细胞系 Caco-2 中的研究
Inorg Chem. 2019 Nov 18;58(22):15536-15551. doi: 10.1021/acs.inorgchem.9b02528. Epub 2019 Nov 7.
3
New bio-sensitive and biologically active single crystal of pyrimidine scaffold ligand and its gold and platinum complexes: DFT, antimicrobial, antioxidant, DNA interaction, molecular docking with DNA/BSA and anticancer studies.嘧啶类骨架配体及其金、铂配合物的新型生物敏感和生物活性单晶:DFT、抗菌、抗氧化、DNA 相互作用、与 DNA/BSA 的分子对接及抗癌研究。
Bioorg Chem. 2018 Dec;81:144-156. doi: 10.1016/j.bioorg.2018.08.006. Epub 2018 Aug 11.
4
In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents.有机金属金(I)衍生物作为抗癌剂的体外和体内评价
Dalton Trans. 2016 Feb 14;45(6):2462-75. doi: 10.1039/c5dt01802a. Epub 2015 Oct 15.
5
Novel Gold(I) Thiolate Derivatives Synergistic with 5-Fluorouracil as Potential Selective Anticancer Agents in Colon Cancer.新型金(I)硫醇衍生物与氟尿嘧啶协同作用,作为结肠癌潜在的选择性抗癌药物。
Inorg Chem. 2017 Jul 17;56(14):8562-8579. doi: 10.1021/acs.inorgchem.7b01370. Epub 2017 Jul 6.
6
New selective thiolate gold(i) complexes inhibit the proliferation of different human cancer cells and induce apoptosis in primary cultures of mouse colon tumors.新型选择性硫醇金(I)配合物抑制不同人癌细胞的增殖,并诱导小鼠结肠肿瘤原代培养物中的细胞凋亡。
Dalton Trans. 2020 Feb 11;49(6):1915-1927. doi: 10.1039/c9dt04423j.
7
Sulfonamide-Derived Dithiocarbamate Gold(I) Complexes Induce the Apoptosis of Colon Cancer Cells by the Activation of Caspase 3 and Redox Imbalance.磺酰胺衍生的二硫代氨基甲酸盐金(I)配合物通过激活半胱天冬酶3和氧化还原失衡诱导结肠癌细胞凋亡。
Biomedicines. 2022 Jun 17;10(6):1437. doi: 10.3390/biomedicines10061437.
8
Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction.设计、合成及三种新型去氢枞哌嗪二硫代氨基甲酸酯钌(II)多吡啶配合物的药理学评价作为潜在的抗肿瘤药物:DNA 损伤、细胞周期阻滞和诱导凋亡。
Molecules. 2021 Mar 7;26(5):1453. doi: 10.3390/molecules26051453.
9
Gold(I) Complexes Bearing Alkylated 1,3,5-Triaza-7-phosphaadamantane Ligands as Thermoresponsive Anticancer Agents in Human Colon Cells.带有烷基化1,3,5-三氮杂-7-磷杂金刚烷配体的金(I)配合物作为人结肠细胞中的热响应性抗癌剂
Biomedicines. 2021 Dec 6;9(12):1848. doi: 10.3390/biomedicines9121848.
10
On the path to gold: Monoanionic Au bisdithiolate complexes with antimicrobial and antitumor activities.走向金:具有抗菌和抗肿瘤活性的单核阴离子 Au 双硫醇配合物。
J Inorg Biochem. 2020 Jan;202:110904. doi: 10.1016/j.jinorgbio.2019.110904. Epub 2019 Oct 22.

引用本文的文献

1
Gold(III) Complexes with Aromatic Cyano-Substituted Bisdithiolate Ligands as Potential Anticancer and Antimicrobial Agents.具有芳香族氰基取代双二硫醇盐配体的金(III)配合物作为潜在的抗癌和抗菌剂
Molecules. 2025 Aug 4;30(15):3270. doi: 10.3390/molecules30153270.
2
Gold(III) Complexes Activity against Multidrug-Resistant Bacteria of Veterinary Significance.金(III)配合物对具有兽医意义的多重耐药细菌的活性。
Antibiotics (Basel). 2022 Dec 1;11(12):1728. doi: 10.3390/antibiotics11121728.
3
Synthesis, characterization, antitumor potential, and investigation of mechanism of action of copper(ii) complexes with acylpyruvates as ligands: interactions with biomolecules and kinetic study.

本文引用的文献

1
Synthesis and Spectroscopic Investigations of Schiff Base Ligand and Its Bimetallic Ag(I) Complex as DNA and BSA Binders.希夫碱配体及其双金属 Ag(I)配合物的合成与光谱研究及其作为 DNA 和 BSA 结合物。
Biomolecules. 2021 Oct 2;11(10):1449. doi: 10.3390/biom11101449.
2
Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis.基于脱铁铁蛋白纳米粒子的独特性质开发治疗神经胶质瘤的新型金(III)试剂:诱导致命自噬和细胞凋亡。
J Med Chem. 2020 Nov 25;63(22):13695-13708. doi: 10.1021/acs.jmedchem.0c01257. Epub 2020 Nov 13.
3
Ruthenium complexes with or -heterocyclic chelates: DNA/BSA binding, antioxidant and anticancer studies.
以酰基丙酮酸为配体的铜(II)配合物的合成、表征、抗肿瘤潜力及作用机制研究:与生物分子的相互作用及动力学研究
RSC Adv. 2022 Oct 26;12(47):30501-30513. doi: 10.1039/d2ra05797b. eCollection 2022 Oct 24.
4
Assessment of physiological and electrochemical effects of a repurposed zinc dithiocarbamate complex on Acinetobacter baumannii biofilms.评估一种已重新利用的二硫代氨基甲酸盐锌配合物对鲍曼不动杆菌生物膜的生理和电化学影响。
Sci Rep. 2022 Jul 9;12(1):11701. doi: 10.1038/s41598-022-16047-z.
钌配合物与 或 -杂环螯合物:DNA/BSA 结合、抗氧化和抗癌研究。
J Biomol Struct Dyn. 2021 Jul;39(11):4077-4088. doi: 10.1080/07391102.2020.1775126. Epub 2020 Jun 11.
4
Gold(iii) bis(dithiolene) complexes: from molecular conductors to prospective anticancer, antimicrobial and antiplasmodial agents.三价金双(二硫烯)配合物:从分子导体到有前景的抗癌、抗菌和抗疟药物。
Metallomics. 2020 Jun 24;12(6):974-987. doi: 10.1039/d0mt00064g.
5
New selective thiolate gold(i) complexes inhibit the proliferation of different human cancer cells and induce apoptosis in primary cultures of mouse colon tumors.新型选择性硫醇金(I)配合物抑制不同人癌细胞的增殖,并诱导小鼠结肠肿瘤原代培养物中的细胞凋亡。
Dalton Trans. 2020 Feb 11;49(6):1915-1927. doi: 10.1039/c9dt04423j.
6
Distorted Gold(I)-Phosphine Complexes as Antifungal Agents.扭曲的金(I)-膦配合物作为抗真菌剂。
J Med Chem. 2020 Mar 12;63(5):2455-2469. doi: 10.1021/acs.jmedchem.9b01436. Epub 2019 Dec 16.
7
Recent progress in the development of organometallics for the treatment of cancer.金属有机化合物在癌症治疗方面的最新进展。
Curr Opin Chem Biol. 2020 Jun;56:28-34. doi: 10.1016/j.cbpa.2019.11.001. Epub 2019 Dec 5.
8
Anticancer Activity of Alkynylgold(I) with P(NMe) Phosphane in Mouse Colon Tumors and Human Colon Carcinoma Caco-2 Cell Line.炔基金(I)与 P(NMe)膦配合物的抗肿瘤活性在小鼠结肠肿瘤和人结肠癌细胞系 Caco-2 中的研究
Inorg Chem. 2019 Nov 18;58(22):15536-15551. doi: 10.1021/acs.inorgchem.9b02528. Epub 2019 Nov 7.
9
On the path to gold: Monoanionic Au bisdithiolate complexes with antimicrobial and antitumor activities.走向金:具有抗菌和抗肿瘤活性的单核阴离子 Au 双硫醇配合物。
J Inorg Biochem. 2020 Jan;202:110904. doi: 10.1016/j.jinorgbio.2019.110904. Epub 2019 Oct 22.
10
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity.抗癌钌(III)配合物及含钌(III)纳米制剂:作用机制与生物活性的最新进展
Pharmaceuticals (Basel). 2019 Sep 26;12(4):146. doi: 10.3390/ph12040146.